Novonesis | NZYM.B (Denmark) | Formed by merger of Novozymes + Chr. Hansen (completed Jan 2024). World’s largest probiotic & enzyme platform. | >40,000 microbial strains; flagship BB-12®, LGG®, FiberCare™, LactoSolve™; >2,000 clinical studies. Sets global standards for gut health and clean-label processing. | Listed on Nasdaq Copenhagen. Long-term bio-manufacturing leader; strong ESG profile and pricing power. | Food enzymes (texture, lactose reduction), probiotics (gut/immune/feminine health), fermentation technology. |
DSM-Firmenich | DSFIR (Netherlands + Switzerland) | World’s largest integrated nutrition + sensory company. Listed on Euronext Amsterdam. Firmenich family holds 43% + golden share. | Combines Life’s DHA® (Omega-3), vitamins, Life’s Probiotics®, and flavor-masking tech. Nutrition sales grew 9% YoY in Q1 2025. EFSA/FDA claim leadership across life stages. | Publicly investable. No dividend during integration (2024–2025), but R&D spend exceeds €1B/year. | Vitamins, Omega-3 (DHA/ARA), probiotics, plant actives, sensory masking solutions. |
Kerry Group | KRY.L (UK) | Global leader in taste + nutrition co-innovation. Nutrition = 58% of 2024 revenue. | ProDiem™ 2.0 (beany-free pea protein); acquired Probio-Max; partnered with MycoTechnology on mycoprotein. Deep integration with Nestlé, PepsiCo, Unilever on “function + flavor” masking. | Premium valuation justified by high-margin innovation and sticky B2B relationships. | Probiotics, plant proteins, dietary fibers, natural emulsification & stabilization systems. |
Archer Daniels Midland (ADM) | ADM (USA) | Vertically integrated “farm-to-formula” nutrition platform. Human Nutrition: $5.1B revenue in 2024 (22% of total). | Acquired Deerland Health (2023); co-leader in Allulose; launched Fibersol®-LG (low-GI fiber). Offers end-to-end sugar reduction & gut health solutions with regulatory support. | Core nutrition business trades at a premium; exposed to three megatrends: plant protein, fiber, and low-sugar. | Allulose, prebiotic fibers, plant proteins, custom nutrient delivery & health claim support. |
Tate & Lyle | TATE.L (UK) | Pure-play health ingredients company after selling sweeteners business in 2023. | Allulose technology leader (patented enzymatic process); Promitor® soluble fiber used by Nestlé, Danone. New Mexico plant online in 2025. Directly enables global sugar taxes & fiber fortification compliance. | High-margin nutrition segment (35%+ gross margin). One of the cleanest exposure to functional carbohydrate trends. | Allulose, soluble corn fiber, prebiotics, clean-label texturization systems. |
Corbion | CRBN.AS (Netherlands) | Global leader in lactic acid & biobased clean-label solutions. | Lumina™ extends plant-based meat shelf-life; Verdad® replaces chemical preservatives via fermentation. Partnered with Novonesis on next-gen prebiotics. EU “Farm to Fork” strategy tailwind. | Small-cap ESG leader (MSCI AA). High relevance in sustainable preservation. | Lactic acid, biopreservatives, clean-label acidulants, fermentation-derived functional ingredients. |
Ajinomoto Co. | 2802.T (Japan) | Global leader in amino acid science; AJI-NO-MOTO® is cash cow. | Commercializing fermentation-derived GABA, theanine, BCAA for cognitive & sports beverages. Launched AminoGut™ for gut-brain axis. High clinical substantiation in Asia. | Food segment stable; health nutrition grew 14% YoY. JPY depreciation supports overseas margins. | Functional amino acids (GABA, theanine, BCAA), umami enhancers, fermented health ingredients. |
Givaudan | GIVN.SW (Switzerland) | World #1 in flavors & fragrances; fully integrated Naturex (plant actives). | Launched Health Ingredients unit: ashwagandha, curcumin, green tea extracts. Developed sugar-free chocolate flavor masking for Nestlé. Strong in premium botanicals. | High-margin business (>45% gross); health ingredients = strategic but smaller growth pillar. | Natural plant extracts, bioactives, flavor-masking for functional foods/beverages. |
Glanbia | GLB.IR (Ireland) | Global leader in performance & active nutrition; exited cheese in 2024. | Nutritional Solutions grew 12% in 2024. BioPerine® (black pepper extract) enhances nutrient absorption. Deep ties to MyProtein, Amazon, and sports brands. | Exposed to whey volatility, but clear nutrition pivot. Benefits from aging and fitness megatrends. | Whey/milk proteins, bioactive peptides, vitamin premixes, absorption enhancers. |
International Flavors & Fragrances (IFF) | IFF (USA) | Formed via merger with DuPont Nutrition (2021); streamlining portfolio in 2024–2025. | Core assets: HOWARU® probiotics, Nutriose® fiber, PURIS™ pea protein. Selling non-core flavor assets to reduce debt. Strong IP but execution lags peers. | High leverage remains concern; nutrition R&D is world-class but undercapitalized. | Probiotics, soluble fibers, plant proteins, stabilization systems. |
Ingredion | INGR (USA) | Transformed from starch processor to health ingredients innovator. | Exited erythritol in 2024; focuses on NUTRAFLX™ pea protein and PREBIOTIC+™ fibers. Collaborating with Coca-Cola on next-gen low-sugar bases. | Short-term headwinds offset by >20% growth in protein/fiber. Strong cash flow supports reinvestment. | Clean-label starches, plant proteins, prebiotic fibers, low-calorie sweetening systems. |
Roquette Frères | N/A (France) | Global leader in pea protein & polyols; family-owned, operates in 100+ countries. | NUTRALYS® S85E pea protein achieves PDCAAS=1.0 (matches whey). New French protein plant (2025). Key supplier to Nestlé, Danone, Beyond Meat. | Private; valued €8B. IPO or acquisition likely long-term; tech lead but scale limited by ownership. | Pea/rice proteins, maltitol, dietary fibers, pharma excipients. |
BENEO | N/A (Belgium) | Subsidiary of Südzucker; global leader in prebiotic fibers & low-GI carbs. | Orafti® inulin/FOS has EFSA-approved claim (“contributes to normal bowel function”). Palatinose™ used in sports nutrition for sustained energy. | Private; stable 8% annual growth. Clinical gold standard, but narrow product scope. | Inulin, FOS, isomaltulose, resistant starch. |
CP Kelco | N/A (USA) | Leading hydrocolloid producer; business unit of DuPont Nutrition & Biosciences. | GENU® pectin for plant-based yogurt; KELCOGEL® gellan gum for clean-label texture; Citrus Fiber for natural emulsification. | Private (within DuPont); not separately investable but critical for texture in plant-based foods. | Pectin, gellan gum, xanthan gum, citrus fiber. |
Lonza Group | LONN.SW (Switzerland) | Global pharma/nutrition CDMO; sold Capsugel in 2024. | Nutrition CDMO: custom probiotics, botanical extracts, gummies, softgels for Amway, Nestlé Health Science. | Pharma CDMO dominates (>80% revenue); nutrition is high-margin but <5% of sales—non-core. | Probiotic CDMO, botanical actives, custom delivery formats (gummies, capsules). |
BASF SE | BAS.DE (Germany) | World’s largest chemical company; spun off agricultural business in 2024. | Nutrition & Care segment: vitamins (B12, D3), carotenoids, food enzymes. Expanded capacity in 2024. Partnered with ADM on rare sugar bioproduction. | Nutrition is a small, stable segment (€2.1B) within a cyclical chemical giant. Dividend yield 5%. | Vitamins, carotenoids, food enzymes, natural plant extracts for fortification. |
Cargill | N/A (USA) | World’s largest private agri-food company; 150+ years family-owned; net-zero by 2030. | Exited low-margin commodity ingredients; focuses on Cargill Health Technologies: Prolide™ high-solubility plant proteins, clean-label texturizers. | Not investable. Systemically influential but low transparency; more commodity than innovation leader. | Plant proteins, clean-label hydrocolloids, custom nutritional blends. |